Arcadia Biosciences, Inc.RKDA

NasdaqEnergyCrude Petroleum & Natural Gas
Price (close)
$0.32
Market cap
—
P/E
—
Revenue (TTM)
$4.7M
Net income
-$11.1M
Dividend yield
—
1-year total return
-91.0%
Net margin
-234.5%
Revenue growth
-12.2%
Debt / equity
—

What Arcadia Biosciences, Inc. does.

Arcadia has leveraged its history as a leader in science-based approaches to develop high value products and drive innovation in the consumer goods industry. Since acquiring the assets of Zola in May 2021, Arcadia has provided consumers with a way to rehydrate, reset, and reenergize with Zola coconut water products. Previously, Arcadia developed products, primarily in wheat, which it commercialized through the sale of food products, trait licensing and royalty agreements.

On May 14, 2024, Arcadia sold its non-GMO Resistant Starch (“RS”) durum wheat trait to longtime partner Corteva Agriscience (“Corteva”) for total cash consideration of $4.0 million. Refer to Note 11 to the consolidated financial statements for further details of the transaction.

On May 16, 2024, Arcadia sold the GoodWheat™ brand to Above Food for net consideration of $3.7 million. The strategic decision to sell GoodWheat enabled the Company to monetize its intellectual property early. The assets sold consisted primarily of grain and finished goods inventories, formulations and trademarks. Refer to Notes 4 and 8 to the consolidated financial statements for further details of the transaction.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$8.0M$6.8M$7.4M$4.5M$5.0M$4.9M
Net income-$4.7M-$14.7M-$15.4M-$14.0M-$7.0M-$2.3M
Free cash flow-$32.6M-$26.9M-$14.0M-$15.3M-$9.6M-$4.7M

More on RKDA.

Figures from Arcadia Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.